D
Teva Pharmaceutical Industries Limited TEVA
$16.33 -$0.13-0.79%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 16.54B 16.77B 16.29B 16.00B 15.85B
Total Other Revenue -- -- -- -- --
Total Revenue 16.54B 16.77B 16.29B 16.00B 15.85B
Cost of Revenue 8.48B 8.41B 8.23B 8.17B 8.20B
Gross Profit 8.06B 8.36B 8.06B 7.83B 7.65B
SG&A Expenses 3.70B 3.65B 3.57B 3.54B 3.50B
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -9.00M -1.00M 11.00M -12.00M 12.00M
Total Operating Expenses 13.17B 13.04B 12.80B 12.66B 12.67B
Operating Income 3.37B 3.73B 3.49B 3.34B 3.18B
Income Before Tax -1.28B -529.00M -143.00M -821.00M -622.00M
Income Tax Expenses 675.00M 688.00M 607.00M -39.00M -6.00M
Earnings from Continuing Operations -1.96K -1.22K -750.00 -782.00 -616.00
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings 320.00M 258.00M 297.00M 303.00M 56.00M
Net Income -1.64B -959.00M -453.00M -479.00M -560.00M
EBIT 3.37B 3.73B 3.49B 3.34B 3.18B
EBITDA 4.43B 4.79B 4.57B 4.46B 4.33B
EPS Basic -1.45 -0.84 -0.40 -0.43 -0.50
Normalized Basic EPS 1.61 1.74 1.64 1.55 1.24
EPS Diluted -1.46 -0.86 -0.41 -0.44 -0.52
Normalized Diluted EPS 1.61 1.73 1.63 1.54 1.22
Average Basic Shares Outstanding 4.52B 4.51B 4.50B 4.49B 4.48B
Average Diluted Shares Outstanding 4.52B 4.53B 4.53B 4.52B 4.51B
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings